Comment regarding benefit in phase 1 oncology trials.
Morse
Michael
M
Division of Medical Oncology, GI Oncology, Molecular Therapeutics Program, Duke South Clinics, Duke University Medical Center, Durham, NC, USA. michael.morse@duke.edu
D017321:Clinical Trials, Phase I as Topic / Q000941:ethics*; D030881:Disclosure; D006801:Humans; D007258:Informed Consent / Q000941:ethics*; D009369:Neoplasms / Q000188:drug therapy*; D010353:Patient Education as Topic; D018570:Risk Assessment; D016896:Treatment Outcome